Skip to main content

Animations

MJFF Publications

7491 - 7500 of 8825 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: RedOx regulation of LRRK2 kinase activity by active site cysteines
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00683-5
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Orthogonal analysis of mitochondrial function in Parkinson’s disease patients
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06617-6
    Citation Count: 13
  • Summary Details
    OPEN
    Title: α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06630-9
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06534-8
    Citation Count: 6
  • Summary Details
    OPEN
    Title: An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00723-x
    Citation Count: 15
  • Summary Details
    OPEN
    Title: APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-024-07185-7
    Citation Count: 424
  • Summary Details
    OPEN
    Title: Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-02886-y
    Citation Count: 106
  • Summary Details
    OPEN
    Title: Single-cell multiplex chromatin and RNA interactions in ageing human brain
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-024-07239-w
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Fusion of biomedical imaging studies for increased sample size and diversity: a case study of brain MRI
    Journal Name: Frontiers in Radiology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fradi.2024.1283392
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49016-3
    Citation Count: 38
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.